Find in Library

In recent years, CRISPR-Cas toolboxes for <i>Streptomyces</i> editing have rapidly accelerated natural product discovery and engineering. However, Cas efficiencies are oftentimes strain-dependent, and the commonly used <i>Streptococcus pyogenes</i> Cas9 (SpCas9) is notorious for having high levels of off-target toxicity effects. Thus, a variety of Cas proteins is required for greater flexibility of genetic manipulation within a wider range of <i>Streptomyces</i> strains. This study explored the first use of <i>Acidaminococcus</i> sp. Cas12j, a hypercompact Cas12 subfamily, for genome editing in <i>Streptomyces</i> and its potential in activating silent biosynthetic gene clusters (BGCs) to enhance natural product synthesis. While the editing efficiencies of Cas12j were not as high as previously reported efficiencies of Cas12a and Cas9, Cas12j exhibited higher transformation efficiencies compared to SpCas9. Furthermore, Cas12j demonstrated significantly improved editing efficiencies compared to Cas12a in activating BGCs in <i>Streptomyces</i> sp. A34053, a strain wherein both SpCas9 and Cas12a faced limitations in accessing the genome. Overall, this study expanded the repertoire of Cas proteins for genome editing in actinomycetes and highlighted not only the potential of recently characterized Cas12j in <i>Streptomyces</i> but also the importance of having an extensive genetic toolbox for improving the editing success of these beneficial microbes.